A regulatory loophole allows businesses to offer potentially ineffective or harmful treatments, a researcher warns

Quick Read

Before behavioral therapy is tried. The Centers for Disease Control and Prevention reported Tuesday that three in four young kids diagnosed with attention deficit hyperactivity disorder are put on medicines

Quick Read

When Pam Lipp’s 18-year-old daughter Amanda needed to be admitted to a psychiatric hospital in 2010, she thought it would be easy to find her a bed. Instead, Lipp says, “It was a nightmare.”

Quick Read

Art Caplan and Carolyn Plunkett: The Zika outbreak sweeping through South America, Central America, Mexico and the Caribbean–and steadily moving north–has made mosquito control a top priority for national and international leaders, including the CDC and WHO

Quick Read

Federal regulators are preparing to crack down on scores of clinics across the United States that offer pricey stem cell therapies for conditions ranging from autism to multiple sclerosis to erectile dysfunction without any scientific evidence that they work

Quick Read

Ask David Ross to describe an average day on the job. He says it doesn’t exist. Ross is a violence intervention specialist at the University of Maryland Medical Center. Though he isn’t a doctor, he’s been working at the hospital as part of its Violence Prevention Program for close to 10 years. His team works with patients who are victims of violent injuries

Quick Read

Widening the use of deep brain stimulation: Ethical considerations in research on DBS to treat Anorexia Nervosa

Quick Read

Adina Roskies: As treatments advance, interventions into brain function will dramatically illustrate the dependence of who we are on our brains – and they may put pressure on some basic beliefs and concepts that have been fundamental to how we view the world

Quick Read